(Q36791591)

16 August 2017

1 reference

title

Age-related changes in pharmacokinetics: predictability and assessment methods (English)

1 reference

16 August 2017

1 reference

1

Emilio Perucca

1 reference

16 August 2017

publication date

1 January 2007

1 reference

International Review of Neurobiology

16 August 2017

published in

1 reference

16 August 2017

volume

81

1 reference

16 August 2017

page(s)

183-199

1 reference

Association between patient age and gabapentin serum concentration-to-dose ratio: a preliminary multivariate analysis

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Differential kinetics of phenytoin in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Variability of total phenytoin serum concentrations within elderly nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Effects of age and gender on single-dose pharmacokinetics of gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Renal elimination of amikacin and the aging process

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Steady-state pharmacokinetics of phenytoin from routinely collected patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetics of vigabatrin: implications of creatinine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The effects of age on carbamazepine pharmacokinetics and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The disposition of primidone in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Age-dependent changes of the kidneys: pharmacological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetic study of levetiracetam in children

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetic variability of new antiepileptic drugs at different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacokinetics of valproic acid in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Pharmacological and clinical aspects of antiepileptic drug use in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Alteration of drug-protein binding in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Single and multiple dose pharmacokinetics of felbamate in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Factors in aging that effect the bioavailability of nutrients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Reduced induction of drug metabolism in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

An evaluation of antiepileptic drug therapy in nursing facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Liver function and phase I drug metabolism in the elderly: a paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Perceptions of differences between pairs of tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Effects of age and cigarette smoking on propranolol disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The effect of age on pharmacokinetics of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Population pharmacokinetics of phenytoin from routine clinical data in Japan: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

The aging liver: structural and functional changes and their consequences for drug treatment in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

Choreoathetosis Induced by Ordinary Phenytoin Levels, Explained by High Free Fraction?—A Case Report

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981011-1

7 January 2021

10.1016/S0074-7742(06)81011-1

Identifiers

DOI

1 reference

16 August 2017

1 reference